ODDB.org: Open Drug Database

Novartis Pharma Schweiz AG - Tafinlar 50 mg, Hartkapseln

Swissmedic Registration	62781	Sequence	01
Product name	Tafinlar 50 mg	Description	Hartkapseln
ATC-Classification	L01EC02	ATC-Description	Dabrafenib
Introduction of Sequence	13.01.2014

Composition

dabrafenibum 50 mg ut dabrafenibi mesilas, cellulosum microcristallinum, magnesii stearas, silica colloidalis anhydrica, Kapselhülle: hypromellosum, E 171, E 172 (rubrum), Drucktinte: lacca, E 172 (nigrum), propylenglycolum, ammonii hydroxidum, pro capsula.

Packungsbestandteile

Galenic Form

Capsules

Active Agent	Dose
Dabrafenibum	50 mg

BAG: Active Agent	Dose
Dabrafenibum	50 mg

Inactive agents		additional_information
(Nigrum)
(Rubrum)
Ammonii Hydroxidum
Cellulosum Microcristallinum
E 171		color.
E 172		color.
Hypromellosum		Kapselhülle
Lacca		Drucktinte
Magnesii Stearas
Pro Capsula
Propylenglycol
Silica Colloidalis Anhydrica

Package number	Package Size	EFP	CP	Category	SL	Out of trade (MedRef)
001	28 Capsule(s)	820.18	908.40	A	SL	No
002	120 Capsule(s)	3515.06	3839.25	A	SL	No

2025	©ywesee GmbH